{"id":"soluble-human-insulin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Soluble human insulin is a rapid-acting insulin that mimics the body's natural insulin hormone. It binds to insulin receptors on muscle, fat, and liver cells, facilitating glucose transport into these cells and promoting glycogen synthesis while inhibiting gluconeogenesis. This results in decreased blood glucose concentration in patients with diabetes mellitus.","oneSentence":"Soluble human insulin binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:37:58.716Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT07432581","phase":"NA","title":"Topical Insulin Dressing on Management of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-01-01","conditions":"Topical, Insulin, Dressing","enrollment":30},{"nctId":"NCT07405944","phase":"PHASE4","title":"Vericiguat and Reverse Remodeling Indices in Heart Failure","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2025-11-01","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Chronic Heart Failure","enrollment":60},{"nctId":"NCT07364669","phase":"PHASE1","title":"Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy Subjects","status":"COMPLETED","sponsor":"Laboratorios Pisa S.A. de C.V.","startDate":"2024-10-24","conditions":"Healthy Subjects","enrollment":40},{"nctId":"NCT06968286","phase":"NA","title":"The Effect of Locally Dilvered Ciprofloxacine Loaded Injectable Platelet-rich Fibrin as an Adjunct to Non-surgical Periodontal Therapy on the Gingival Crevicular Level of Interleukin 6","status":"COMPLETED","sponsor":"Suez Canal University","startDate":"2025-01-01","conditions":"Periodontitis Stage II","enrollment":60},{"nctId":"NCT05570435","phase":"NA","title":"Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2022-11-16","conditions":"Healthy, PreDiabetes, Adult","enrollment":31},{"nctId":"NCT06895018","phase":"NA","title":"Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"Federico II University","startDate":"2024-05-03","conditions":"Diabetes Mellitus Type 2","enrollment":20},{"nctId":"NCT05399134","phase":"NA","title":"Glycemic Evaluation of Novel Staple Foods","status":"COMPLETED","sponsor":"National University of Singapore","startDate":"2021-01-01","conditions":"Diabete Type 2, Diabetes Mellitus","enrollment":20},{"nctId":"NCT06368297","phase":"NA","title":"The Effect of Ketone Ester Supplementation and Ketogenic Diet on Brain Plasticity in Overweight/Obese Adults","status":"NOT_YET_RECRUITING","sponsor":"University of Macau","startDate":"2024-04","conditions":"Overweight and Obesity, Cognitive Change, Psychophysiologic Reaction","enrollment":40},{"nctId":"NCT06032260","phase":"NA","title":"The Effects of a Fiber-enriched Bakery Product on Glucose, Insulin Values and Appetite","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2023-01-20","conditions":"Healthy","enrollment":10},{"nctId":"NCT03486223","phase":"PHASE2","title":"Soluble Epoxide Hydrolase Inhibition and Insulin Resistance","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2018-05-17","conditions":"Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders","enrollment":16},{"nctId":"NCT03708419","phase":"NA","title":"Personalized Glucose Optimization Through Nutritional Intervention","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2018-06-04","conditions":"Obesity, Pre-diabetic, Type 2 Diabetes Mellitus","enrollment":242},{"nctId":"NCT04499287","phase":"NA","title":"Mealtime Walking Study to Improve Postprandial Metabolic Response","status":"COMPLETED","sponsor":"Arizona State University","startDate":"2014-09-17","conditions":"PreDiabetes, Postprandial Hyperglycemia","enrollment":10},{"nctId":"NCT03535935","phase":"PHASE2, PHASE3","title":"Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2018-07-01","conditions":"Diabetic Nephropathies, Diabetic Kidney Disease","enrollment":118},{"nctId":"NCT03424044","phase":"PHASE1","title":"Three Way Crossover Closed Loop Study With Xeris Glucagon","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2018-03-29","conditions":"Type1diabetes","enrollment":23},{"nctId":"NCT04226105","phase":"PHASE3","title":"Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Geropharm","startDate":"2020-01-20","conditions":"Diabetes Mellitus, Type 2, Diabetes Mellitus","enrollment":264},{"nctId":"NCT04022291","phase":"PHASE1","title":"Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30","status":"COMPLETED","sponsor":"Biocon Limited","startDate":"2019-06-15","conditions":"Healthy Volunteer","enrollment":78},{"nctId":"NCT03460899","phase":"NA","title":"Impact of Hypoglycaemia in Patients With Diabetes Mellitus Type 2 on Platelet Activation","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2018-02-12","conditions":"Diabetes Mellitus With Hypoglycemia, Diabetes Mellitus, Type 2, Hypoglycemia","enrollment":14},{"nctId":"NCT03622762","phase":"PHASE2","title":"Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy","status":"UNKNOWN","sponsor":"Centro Universitario de Ciencias de la Salud, Mexico","startDate":"2018-07-15","conditions":"Diabetic Nephropathy Type 2","enrollment":30},{"nctId":"NCT03736109","phase":"","title":"Role of Copper-Albumin Complex in Treatment of Knee Osteoarthritis in Human","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-01-17","conditions":"Osteo Arthritis Knee","enrollment":60},{"nctId":"NCT01009580","phase":"PHASE3","title":"Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-11-05","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":447},{"nctId":"NCT03003897","phase":"","title":"Meta-analysis of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Overweight and Obese Adults.","status":"COMPLETED","sponsor":"University of Illinois at Urbana-Champaign","startDate":"2016-01","conditions":"Obesity","enrollment":609},{"nctId":"NCT02289612","phase":"NA","title":"Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products","status":"COMPLETED","sponsor":"University of Guelph","startDate":"2014-11","conditions":"Type 2 Diabetes Mellitus","enrollment":15},{"nctId":"NCT01789593","phase":"PHASE1","title":"A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-01-14","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":29},{"nctId":"NCT01486966","phase":"PHASE4","title":"Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2011-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":58},{"nctId":"NCT00676819","phase":"PHASE4","title":"Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-01-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":19},{"nctId":"NCT00567775","phase":"PHASE2","title":"Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-10-21","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":27},{"nctId":"NCT01492153","phase":"","title":"NovoLet® Surveillance Study on Using Human Insulin System in Indonesia","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-02-11","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":1981},{"nctId":"NCT02204384","phase":"NA","title":"Glycemic and Insulinemic Response With Different Sources of Soluble Fiber in Patients Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2014-08","conditions":"Dietary Modification, Diabetes Mellitus Type 2, Insulin Tolerance","enrollment":19},{"nctId":"NCT01006291","phase":"PHASE3","title":"Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":687},{"nctId":"NCT01542489","phase":"","title":"Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-10","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":480},{"nctId":"NCT01486940","phase":"PHASE3","title":"Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-03","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":598},{"nctId":"NCT01780272","phase":"PHASE1","title":"A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-01","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":26},{"nctId":"NCT01520831","phase":"PHASE1","title":"Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1999-04","conditions":"Diabetes, Healthy","enrollment":35},{"nctId":"NCT01707134","phase":"PHASE3","title":"Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1997-09","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":753},{"nctId":"NCT00597233","phase":"PHASE4","title":"Human Insulin NPH and Insulin Aspart in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-10","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":91},{"nctId":"NCT00593255","phase":"PHASE4","title":"Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-07","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":220},{"nctId":"NCT00410033","phase":"NA","title":"Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1989-12","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":74},{"nctId":"NCT00571935","phase":"PHASE4","title":"Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-08","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":61},{"nctId":"NCT02962622","phase":"NA","title":"Cognition Metabolism and Exercise Among Women Living With HIV in Puerto Rico","status":"UNKNOWN","sponsor":"University of Puerto Rico","startDate":"2014-11","conditions":"HIV","enrollment":45},{"nctId":"NCT00715780","phase":"","title":"Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-06","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":1667},{"nctId":"NCT00427973","phase":"PHASE2","title":"AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-05","conditions":"Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer","enrollment":17},{"nctId":"NCT00698126","phase":"","title":"Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":4099},{"nctId":"NCT02634515","phase":"PHASE1","title":"Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal","status":"COMPLETED","sponsor":"Julphar Gulf Pharmaceutical Industries","startDate":"2014-12","conditions":"Diabetes Mellitus","enrollment":26},{"nctId":"NCT02281253","phase":"NA","title":"Effects of a Bakery Product Enriched With Fibre and L-carnitine on Insulin Resistance in Patients With Metabolic Syndrome","status":"COMPLETED","sponsor":"Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana","startDate":"2010-04","conditions":"Metabolic X Syndrome, Overweight, Dyslipidemias","enrollment":54},{"nctId":"NCT02162407","phase":"PHASE1","title":"A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1999-10","conditions":"Diabetes, Healthy","enrollment":13},{"nctId":"NCT01121835","phase":"PHASE4","title":"Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-02","conditions":"Diabetes Mellitus, Type 2","enrollment":934},{"nctId":"NCT00596063","phase":"PHASE1","title":"Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.","status":"COMPLETED","sponsor":"Wockhardt","startDate":"2008-01","conditions":"Diabetes Mellitus","enrollment":25},{"nctId":"NCT00752180","phase":"PHASE1","title":"Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics","status":"COMPLETED","sponsor":"Wockhardt","startDate":"2008-08","conditions":"Diabetes","enrollment":28},{"nctId":"NCT00719108","phase":"PHASE1","title":"Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.","status":"COMPLETED","sponsor":"Wockhardt","startDate":"2008-07","conditions":"Diabetes","enrollment":42},{"nctId":"NCT01005342","phase":"NA","title":"Influence of Dietary Fiber-rich Meals on Gene Expression and Postprandial Glucose and Lipid Response","status":"COMPLETED","sponsor":"Lund University","startDate":"2007-05","conditions":"Hypoglycemia, Hyperglycemia","enrollment":18},{"nctId":"NCT00513643","phase":"PHASE1","title":"Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses","status":"COMPLETED","sponsor":"Profil Institut für Stoffwechselforschung GmbH","startDate":"2002-04","conditions":"Diabetes Mellitus","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":66,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Actrapid®","Actrapid"],"phase":"marketed","status":"active","brandName":"soluble human insulin","genericName":"soluble human insulin","companyName":"Novo Nordisk A/S","companyId":"novo-nordisk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Soluble human insulin binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}